Webinar: Beyond Urine and Saliva – Introducing Fingerprint Drug Testing

Webinar- Introducing Fingerprint Drug Testing

Share This Post

Webinar: Thursday November 20th

Time: 4PM AEDT | 9AM GST | 2PM JST | 10:30AM IST

Discover a faster, non-invasive, and more efficient approach to workplace drug testing. See firsthand how fingerprint drug testing streamlines sample collection, reduces labor, and improves compliance.

Why Traditional Testing Falls Short

Explore the limitations and challenges of traditional workplace drug testing methods, including urine and saliva. See how fingerprint sweat-based drug testing offers a faster, non-invasive, and more efficient alternative.

In this webinar, we’ll explore:

  • Limits of Traditional Drug Tests: Understand the operational, logistical, and employee experience challenges with traditional urine and saliva testing.
  • Fingerprint Drug Testing in Action: Watch a live demonstration of sample collection, analysis, and reporting.
  • Real-World Benefits: Learn the operational benefits of fingerprint drug testing.
  • Why It Works: Gain practical insights into why fingerprint testing is a compelling option for organizations looking to modernize their drug testing approach.

Speakers

Doug Heath, Vice President of Global Sales, Intelligent Bio Solutions

Peter Passaris, Vice President of Product Development, Intelligent Bio Solutions

Jayson Langley, Content Specialist, Intelligent Fingerprinting

Reserve Your Spot

Learn how Intelligent Bio Solutions (INBS) is commercializing its med tech solutions and expanding access to non-invasive testing.

What Intelligent Bio Solutions Does and The Problem It Solves

Intelligent Bio Solutions Inc. (Nasdaq: INBS) is a med tech company focused on delivering intelligent, rapid, non-invasive testing solutions. The company’s flagship product, the Intelligent Fingerprinting Drug Screening System, analyzes fingerprint sweat to detect drug use, supporting workplace safety across safety-critical industries, government and law-enforcement settings. INBS’ story is about more than an alternative approach…

INBS Achieves Key Milestone Ahead of FDA 510(k) Submission

Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry

NEW YORK, July 23, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it has addressed all the cybersecurity and software-related review items for its upcoming FDA 510(k) submission. This follows the Company’s recent completion of independent third-party penetration…

Sign Up

Subscribe to receive the latest news and updates from Intelligent Bio Solutions.

Request a Fingerprint Drug Test Demonstration

Non-invasive, cost-effective, and efficient workplace drug testing

Learn how our Intelligent Fingerprinting Drug Test can work for your business.

Book a no-obligation online or in-person demonstration today.